JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 14 No. 11 840-842
© 1973 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watson, E. E.
Right arrow Articles by Gibbs, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watson, E. E.
Right arrow Articles by Gibbs, W. D.

Whole-Body Retention of 67Ga-Citrate

Evelyn E. Watson, Roger J. Cloutier and William D. Gibbs

Oak Ridge Associated Universities, Oak Ridge, Tennessee

Correspondence: For reprints contact: Evelyn E. watson, Medical Div., Oak Ridge Associated Universities, P.O. Box 117, Oak Ridge, Tenn. 37830.

ABSTRACT

The retention of 67Ga-citrate in patients with neoplastic diseases was measured with a whole body counter which has a counting efficiency essentially independent of patient size and radionuclide distribution. From 2 to 5 mCi of 67Ga-citrate were administered to each patient. Stable gallium constituted <3 µg/dose. The whole-body counting results were analyzed to determine whether differences in uptake and retention could be related to sex or age of the patients. Although there was great variation among patients, biological half-time of the 67Ga was longer in the females than the half-time in the males. No significant differences could be shown to relate to the patients' ages.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1973 by the Society of Nuclear Medicine.